CONMED Corporation (CNMD)

Market Cap	1.43B -3.4%
Revenue (ttm)	1.37B +3.4%
Net Income	56.50M -48.7%
EPS	1.84 -48.0%
Shares Out	29.95M
PE Ratio	25.90
Forward PE	10.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	386,605
Open	48.78
Previous Close	49.25
Day's Range	47.56 - 49.73
52-Week Range	31.44 - 53.66
Beta	0.94
Analysts	Hold
Price Target	45.50 (-4.57%)
Earnings Date	Oct 28, 2026

About CNMD

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as powered resection instruments, fluid management and visualization systems, and related single-use products...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 23, 1987
• Employees: 3,900
• Stock Exchange: NYSE
• Ticker Symbol: CNMD
• Website: https://www.conmed.com

Financial Performance

In 2025, CONMED's revenue was $1.37 billion, an increase of 5.18% compared to the previous year's $1.31 billion. Earnings were $47.06 million, a decrease of -64.47%.

Analyst Summary

According to 7 analysts, the average rating for CNMD stock is "Hold." The 12-month stock price target is $45.5, which is a decrease of -4.57% from the latest price.

Price Target

$45.5

(-4.57% downside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 27, 2026

Data Sources Report a data error